UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

              Date of Report (date of earliest event reported): June 25, 2015


                               CEL-SCI CORPORATION
                      ------------------------------------
             (Exact name of Registrant as specified in its charter)



      Colorado                        0-11503                  84-0916344
----------------------------     ---------------------     --------------------
(State or other jurisdiction     (Commission File No.)       (IRS Employer
    of incorporation)                                       Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                ------------------------------------------------
          (Address of principal executive offices, including Zip Code)



Registrant's telephone number, including area code: (703) 506-9460


                                       N/A
                         -----------------------------
          (Former name or former address if changed since last report)


                                       1
<PAGE>


Item 5.02  Departure of Directors or Certain  Officers;  Election of  Directors;
           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

     On  June  25,  2015,  the  Company,  pursuant  to  the  provisions  of  its
Non-Qualified  Stock  Option Plan,  granted  options to the  following  officers
and/or directors upon the terms shown below:

                       Shares Issuable
                        Upon Exercise       Exercise          Expiration
Name                     of Option (1)       Price               Date
----                   ---------------      --------          ---------

Maximilian de Clara        125,000           $0.66            6/21/2025
Peter Young                125,000           $0.66            6/21/2025
Alexander Esterhazy        125,000           $0.66            6/21/2025
Bruno Baillavoine          125,000           $0.66            6/21/2025

(1)  Options to purchase the first 41,667 shares will be exercisable on June 22,
     2016,  options to purchase the next 41,667  shares will be  exercisable  on
     June 22, 2017 and options to purchase the  remaining  41,666 shares will be
     exercisable  on June 22, 2018. If the option holder ceases to be a director
     for any reason prior to June 22, 2018,  then any options which are not then
     exercisable will expire.

     The  grant  of the  options  was  approved  by the  Company's  Compensation
Committee and board of directors.



                                       2
<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:  June 29, 2015                  CEL-SCI CORPORATION



                                      By: /s/ Patricia B. Prichep
                                          -------------------------------------
                                          Patricia B. Prichep
                                          Senior Vice President of Operations













                                       3
[{"type": "8-K", "sequence": "1", "filename": "form8kitem502stkop6-15.txt", "description": "8-K RE STOCK OPTIONS PER NON-QUALIFIED STK OPTION PLAN", "secsgml_size_bytes": 3628}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "15960820"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

              Date of Report (date of earliest event reported): June 25, 2015

                               CEL-SCI CORPORATION
                      ------------------------------------
             (Exact name of Registrant as specified in its charter)

      Colorado                        0-11503                  84-0916344
----------------------------     ---------------------     --------------------
(State or other jurisdiction     (Commission File No.)       (IRS Employer
    of incorporation)                                       Identification No.)

                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                ------------------------------------------------
          (Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
                         -----------------------------
          (Former name or former address if changed since last report)

                                       1
Item 5.02  Departure of Directors or Certain  Officers;  Election of  Directors;
           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

     On  June  25,  2015,  the  Company,  pursuant  to  the  provisions  of  its
Non-Qualified  Stock  Option Plan,  granted  options to the  following  officers
and/or directors upon the terms shown below:

                       Shares Issuable
                        Upon Exercise       Exercise          Expiration
Name                     of Option (1)       Price               Date
----                   ---------------      --------          ---------

Maximilian de Clara        125,000           $0.66            6/21/2025
Peter Young                125,000           $0.66            6/21/2025
Alexander Esterhazy        125,000           $0.66            6/21/2025
Bruno Baillavoine          125,000           $0.66            6/21/2025

(1)  Options to purchase the first 41,667 shares will be exercisable on June 22,
     2016,  options to purchase the next 41,667  shares will be  exercisable  on
     June 22, 2017 and options to purchase the  remaining  41,666 shares will be
     exercisable  on June 22, 2018. If the option holder ceases to be a director
     for any reason prior to June 22, 2018,  then any options which are not then
     exercisable will expire.

     The  grant  of the  options  was  approved  by the  Company's  Compensation
Committee and board of directors.

                                       2
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  June 29, 2015                  CEL-SCI CORPORATION

                                      By: /s/ Patricia B. Prichep
                                          -------------------------------------
                                          Patricia B. Prichep
                                          Senior Vice President of Operations

                                       3